Edwards Lifesciences Dirección
Dirección controles de criterios 3/4
El CEO de Edwards Lifesciences es Bernard Zovighian , nombrado en May 2023, tiene una permanencia de 1.5 años. compensación anual total es $12.87M, compuesta por 7.6% salario y 92.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.012% de las acciones de la empresa, por valor de $4.84M. La antigüedad media del equipo directivo y de la junta directiva es de 5.2 años y 4.5 años, respectivamente.
Información clave
Bernard Zovighian
Chief Executive Officer (CEO)
US$12.9m
Compensación total
| Porcentaje del salario del CEO | 7.6% |
| Permanencia del CEO | 1.5yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | 5.2yrs |
| Promedio de permanencia en la Junta Directiva | 4.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 11
Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
Oct 25Bearish: Analysts Just Cut Their Edwards Lifesciences Corporation (NYSE:EW) Revenue and EPS estimates
Sep 11Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$13m | US$973k | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$3m | US$642k | US$2b |
Compensación vs. Mercado: La compensación total ($USD12.87M) de Bernard está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD12.74M).
Compensación vs. Ingresos: La compensación de Bernard ha aumentado más de un 20% en el último año.
CEO
Bernard Zovighian (56 yo)
1.5yrs
Permanencia
US$12,869,020
Compensación
Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$12.87m | 0.012% $ 4.8m | |
| Corporate VP & CFO | 10.8yrs | US$5.95m | 0.046% $ 18.5m | |
| Corporate Vice President of Strategy & Corporate Development | 8.8yrs | US$4.29m | 0.035% $ 14.0m | |
| Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.8yrs | US$5.40m | 0.030% $ 12.1m | |
| Principal Accounting Officer | less than a year | sin datos | 0.00030% $ 119.9k | |
| Corporate VP of Advanced Technology & Chief Scientific Officer | 5.8yrs | sin datos | sin datos | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Corporate VP & General Counsel | 5.2yrs | sin datos | sin datos | |
| Corporate Vice President of Public Affairs | 11.4yrs | sin datos | sin datos | |
| Corporate Vice President of Human Resources | 12.3yrs | sin datos | sin datos | |
| Senior Vice President of Quality & Regulatory Compliance | 1.3yrs | sin datos | sin datos | |
| GM & Senior VP of Surgical Structural Heart | 1.3yrs | sin datos | 0.00021% $ 83.9k |
5.2yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de EW es experimentado (5.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$12.87m | 0.012% $ 4.8m | |
| Independent Director | 9.8yrs | US$335.06k | 0.012% $ 4.9m | |
| Independent Director | 4.3yrs | US$329.97k | 0.0013% $ 523.5k | |
| Independent Director | 8.7yrs | US$335.06k | 0.012% $ 4.8m | |
| Independent Director | 8.3yrs | US$356.42k | 0.0046% $ 1.8m | |
| Independent Chairman | 10yrs | US$347.97k | 0.012% $ 4.7m | |
| Independent Director | less than a year | sin datos | sin datos | |
| Director | less than a year | sin datos | sin datos | |
| Independent Director | 4.5yrs | US$334.97k | 0.0019% $ 747.3k |
4.5yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de EW se considera experimentada (4.5 años de antigüedad promedio).